IT1254453B - Composizioni farmaceutiche per uso orale a base di glutatione ridotto - Google Patents
Composizioni farmaceutiche per uso orale a base di glutatione ridottoInfo
- Publication number
- IT1254453B IT1254453B ITMI920317A ITMI920317A IT1254453B IT 1254453 B IT1254453 B IT 1254453B IT MI920317 A ITMI920317 A IT MI920317A IT MI920317 A ITMI920317 A IT MI920317A IT 1254453 B IT1254453 B IT 1254453B
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical compositions
- oral use
- use based
- reduced glutathione
- gsh
- Prior art date
Links
- 108010024636 Glutathione Proteins 0.000 title 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Composizione farmaceutica orale per la somministrazione orale comprendente:a) GSH, come principio attivo,b) un antiossidante,c) un tensioattivo d) un materiale gastroresistente ed enterosolubile;e) un veicolo solido o liquido.Le composizione dell'invenzione permettono la somministrazione orale di GSH.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI920317A IT1254453B (it) | 1992-02-14 | 1992-02-14 | Composizioni farmaceutiche per uso orale a base di glutatione ridotto |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI920317A IT1254453B (it) | 1992-02-14 | 1992-02-14 | Composizioni farmaceutiche per uso orale a base di glutatione ridotto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI920317A0 ITMI920317A0 (it) | 1992-02-14 |
| ITMI920317A1 ITMI920317A1 (it) | 1993-08-14 |
| IT1254453B true IT1254453B (it) | 1995-09-25 |
Family
ID=11361967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI920317A IT1254453B (it) | 1992-02-14 | 1992-02-14 | Composizioni farmaceutiche per uso orale a base di glutatione ridotto |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1254453B (it) |
-
1992
- 1992-02-14 IT ITMI920317A patent/IT1254453B/it active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI920317A0 (it) | 1992-02-14 |
| ITMI920317A1 (it) | 1993-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9913857A (pt) | Formulações de proteìna | |
| DE69307977D1 (de) | Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen | |
| MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
| GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
| WO2002080976A3 (en) | Hsa-free formulations of interferon-beta | |
| TW355683B (en) | Composition containing micronized nebivolol | |
| BR9611802A (pt) | Composições farmacêuticas | |
| CA2294783A1 (fr) | Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine | |
| HUP9901144A2 (hu) | Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények | |
| ES2175413T3 (es) | Formulaciones de aerosol. | |
| AU2001289438A1 (en) | Pharmaceutical semi-solid composition of isotretinoin | |
| ATE287264T1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
| AU3868997A (en) | Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol | |
| CA2173147A1 (en) | Anti-obesity agent | |
| ZA200007415B (en) | Amino acid derivatives and drugs containing the same as the active ingredient. | |
| BR9809708A (pt) | Composições farmacêuticas de peptìdeos tendo solubilidade baixa em meio fisiológico | |
| DE59306211D1 (de) | Diphosphonsäuren und deren salze enthaltende arzneimittel | |
| EP1084710A4 (en) | DRUGS AGAINST MALE STERILITY | |
| IT1254453B (it) | Composizioni farmaceutiche per uso orale a base di glutatione ridotto | |
| EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
| CA2429793A1 (en) | Interferon therapeutic effect enhancer | |
| AU4040195A (en) | Topical composition containing penciclovir | |
| DE69902925D1 (de) | Ramoplaninhaltige neue injizierbare arzneizubereitungen | |
| ZA943648B (en) | Medicament aerosol formulation based on fusafungine a process for its preparation and pharmaceutical compositions containing it | |
| ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970226 |